| |
| |
|
| Insider
Information: |
Baker Mark Robert |
| Relationship: |
CEO, Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
161,141 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$660,678 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
161,141 |
|
|
| Total
Value |
$660,678 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
CEO, Director |
2013-03-27 |
161,141 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2006-10-02 |
4 |
OE |
$19.58 |
$12,277 |
D/D |
627 |
11,412 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2011-11-23 |
4 |
S |
$5.45 |
$3,455 |
D/D |
(634) |
38,313 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2013-03-27 |
4 |
AB |
$5.31 |
$3,458 |
D/D |
650 |
161,141 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2007-10-01 |
4 |
D |
$22.39 |
$15,248 |
D/D |
(681) |
24,877 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2005-10-03 |
4 |
A |
$24.67 |
$17,491 |
D/D |
709 |
2,196 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2007-10-01 |
4 |
OE |
$19.03 |
$14,234 |
D/D |
748 |
25,558 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-08-22 |
4 |
AB |
$4.23 |
$3,451 |
D/D |
815 |
42,641 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2008-01-02 |
4 |
D |
$18.03 |
$15,037 |
D/D |
(834) |
25,020 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2008-01-02 |
4 |
OE |
$15.33 |
$14,042 |
D/D |
916 |
25,854 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2005-07-01 |
4 |
A |
$17.73 |
$17,500 |
D/D |
987 |
1,487 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-09-26 |
4 |
AB |
$3.32 |
$3,440 |
D/D |
1,036 |
43,677 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-12-26 |
4 |
AB |
$3.01 |
$3,437 |
D/D |
1,142 |
158,014 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-10-24 |
4 |
AB |
$2.96 |
$3,434 |
D/D |
1,162 |
44,839 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2013-01-22 |
4 |
AB |
$2.82 |
$3,429 |
D/D |
1,215 |
159,229 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2013-02-27 |
4 |
AB |
$2.71 |
$3,434 |
D/D |
1,262 |
160,491 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-11-28 |
4 |
AB |
$2.12 |
$3,419 |
D/D |
1,607 |
156,872 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2008-10-01 |
4 |
D |
$13.93 |
$22,720 |
D/D |
(1,631) |
27,196 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2009-01-02 |
4 |
D |
$10.74 |
$19,858 |
D/D |
(1,849) |
27,487 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2009-01-02 |
4 |
OE |
$9.13 |
$18,561 |
D/D |
2,033 |
29,336 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2010-03-18 |
4 |
AS |
$5.33 |
$11,539 |
D/D |
(2,165) |
28,423 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2008-04-01 |
4 |
D |
$7.67 |
$17,679 |
D/D |
(2,305) |
25,417 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2010-06-22 |
4 |
S |
$5.66 |
$13,186 |
D/D |
(2,328) |
26,689 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2008-10-01 |
4 |
OE |
$6.53 |
$15,626 |
D/D |
2,393 |
28,827 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2008-04-01 |
4 |
OE |
$6.52 |
$16,515 |
D/D |
2,533 |
27,722 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2006-07-03 |
4 |
D |
$24.26 |
$67,152 |
D/D |
(2,768) |
2,738 |
0 |
- |
|
76 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
